
Ribociclib succinate hydrate is an orally bioavailable and селективный, ингибитор of both CDK4 and CDK6 с IC50 values of 10 nM and 39 nM, respectively. It exhibits anticancer activitiy and can be used in breast cancer, melanoma, liposarcoma, non–small клетка lung cancer, and neuroblastoma therapy research.
Ribociclib succinate hydrate is an orally bioavailable and selective, inhibitor of both CDK4 and CDK6 with IC50 values of 10 nM and 39 nM, respectively. It exhibits anticancer activitiy and can be used in breast cancer, melanoma, liposarcoma, non–small cell lung cancer, and neuroblastoma therapy research.
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.